Logo Image
News
All NewsFDA UpdatesPress Releases
Media
All VideosDigital DetailIndependent CornerInsightsInterviewsMEDcastMEDcast SeriesMedical World NewsMicrositesPeer ExchangePerfect ConsultPodcastsPractice PearlsShortsSponsored WebcastStudent VoicesThe Weekly DoseWebinars/Webcasts
Conferences
Conference CoverageConference Listing
Publications
All PublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthThe Bispecifics NetworkEducated PatientInformation for the PharmacistInteractive ToolsPartnersPulse PointSponsoredWhiteboards

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • ADHD
  • Allergy
    • Asthma
  • Anxiety
  • Biosimilars
  • Bipolar Disorder
  • Brain Health
  • Breast Cancer
  • COPD
  • Cardiovascular Health
    • Heart Failure
    • Cholesterol
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chronic Kidney Disease
  • Classical Hematology
    • Immunoglobulins
    • Neutropenia
  • Colorectal Cancer
  • Cough and Cold
  • Depression
  • Dermatology
    • Psoriasis
    • Atopic Dermatitis
  • Dry Eye Disease
  • Endocrinology
    • Continuous Glucose Monitoring
    • Diabetes
    • Osteoporosis
  • Endometrial Cancer
  • Epilepsy
  • Eye Care
  • Future of Pharmacy
  • Gastrointestinal Cancer
  • Gastrointestinal Health
    • Digestive Health
  • Gout
  • HER2 Breast Cancer
  • Hematology
    • Multiple Myeloma
    • Lymphoma
    • Myelofibrosis
    • Chronic Lymphocytic Leukemia
  • Hepatitis/MASH
  • Immuno-oncology
  • Infectious Disease
    • Respiratory Syncytial Virus
    • Pneumococcal
    • C. difficile
    • COVID-19
    • Flu
    • HIV
    • PrEP
  • Lung Cancer
  • Macular Degeneration
  • Mental Health
  • Migraine
  • Movement Disorders
  • Multiple Sclerosis
  • Neurology
    • Alzheimer Disease
  • Ovarian Cancer
  • Pain Management
  • Parkinson Disease
  • Pediatrics
  • Prostate Cancer
  • Psoriatic Arthritis
  • Psychedelics
  • Reproductive Health
  • Rheumatoid Arthritis
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep
  • Vaccines
    • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

Christian A. Hartman, BSPharm, RPh

Advertisement

Articles by Christian A. Hartman, BSPharm, RPh

RxPRODUCT NEWS PROFILE: Namenda

ByChristian A. Hartman, BSPharm, RPh,Claudio Faria, PharmD, RPh
March 1st 2004

Levitra (vardenafil, Bay 38-9456)

ByChristian A. Hartman, BSPharm, RPh,Claudio Faria, PharmD, RPh
December 1st 2003

Reyataz (Atazanavir sulfate, BMS-232632)

ByChristian A. Hartman, BSPharm, RPh,Claudio Faria, PharmD, RPh
November 1st 2003

Crestor (Rosuvastatin, ZD4522)

ByChristian A. Hartman, BSPharm, RPh,Claudio Faria, PharmD, RPh
September 1st 2003

Iressa (Gefitinib, ZD1839)

ByChristian A. Hartman, BSPharm, RPh,Claudio Faria, PharmD, RPh
July 1st 2003

Fuzeon (Enfuvirtide, formerly T-20 and pentafuside)

ByChristian A. Hartman, BSPharm, RPh,Claudio Faria, PharmD, RPh
June 1st 2003

Zetia (Ezetimibe, SCH-58235)

ByChristian A. Hartman, BSPharm, RPh,Claudio Faria, PharmD, RPh
May 1st 2003

Humira (adalimumab, D2E7)

ByChristian A. Hartman, BSPharm, RPh,Claudio Faria, PharmD, RPh
March 1st 2003
Advertisement

Latest Updated Articles

  • RxPRODUCT NEWS PROFILE: Namenda
    RxPRODUCT NEWS PROFILE: Namenda

    March 1st 2004

  • Levitra (vardenafil, Bay 38-9456)
    Levitra (vardenafil, Bay 38-9456)

    December 1st 2003

  • Reyataz (Atazanavir sulfate, BMS-232632)
    Reyataz (Atazanavir sulfate, BMS-232632)

    November 1st 2003

  • Crestor (Rosuvastatin, ZD4522)
    Crestor (Rosuvastatin, ZD4522)

    September 1st 2003

  • Iressa (Gefitinib, ZD1839)
    Iressa (Gefitinib, ZD1839)

    July 1st 2003

  • Fuzeon (Enfuvirtide, formerly T-20 and pentafuside)
    Fuzeon (Enfuvirtide, formerly T-20 and pentafuside)

    June 1st 2003



Advertisement
Advertisement

Trending on Pharmacy Times

1

mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months

2

Navigating REMS: Challenges, Perspectives, and the Path Forward for Bispecific Antibody Programs

3

FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC

4

Building a Pharmacist-Led Furoscix Workflow From Scratch

5

The Precision Prescription: How Automation Is Revolutionizing Medication Safety

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us